Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Fromm

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Plos One|January 4, 2013
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potentialSébastien Anguille, Eva Lion, Jurjen Tel, et al.
Pharmacological Reviews|August 5, 2015
Dendritic Cells as Pharmacological Tools for Cancer ImmunotherapySébastien Anguille, Evelien L Smits, Christian Bryant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2016
Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell MigrationTsun-Ho Lo, Pablo A Silveira, Phillip D Fromm, et al.
Plos One|May 11, 2019
Examination of CD302 as a potential therapeutic target for acute myeloid leukemiaTsun-Ho Lo, Edward Abadir, Robin E Gasiorowski, et al.
Immunology and Cell Biology|January 22, 2016
A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subsetChristian Bryant, Phillip D Fromm, Fiona Kupresanin, et al.
Science (New York, N.Y.)|August 10, 2019
Black carbon lofts wildfire smoke high into the stratosphere to form a persistent plumePengfei Yu, Owen B Toon, Charles G Bardeen, et al.
Molecular Oncology|July 25, 2019
CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiationEdward Abadir, Robin E Gasiorowski, Kaitao Lai, et al.
Oncoimmunology|April 11, 2018
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remissionJennifer L Hsu, Christian E Bryant, Michael S Papadimitrious, et al.
Science Advances|December 10, 2025
Enhanced radiative cooling by large aerosol particles from wildfire-driven thunderstormsYaowei Li, John A Dykema, David A Peterson, et al.
Haematologica|January 21, 2018
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphomaZiduo Li, Xinsheng Ju, Kenneth Lee, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Plos One|January 4, 2013
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potentialSébastien Anguille, Eva Lion, Jurjen Tel, et al.
Pharmacological Reviews|August 5, 2015
Dendritic Cells as Pharmacological Tools for Cancer ImmunotherapySébastien Anguille, Evelien L Smits, Christian Bryant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2016
Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell MigrationTsun-Ho Lo, Pablo A Silveira, Phillip D Fromm, et al.
Plos One|May 11, 2019
Examination of CD302 as a potential therapeutic target for acute myeloid leukemiaTsun-Ho Lo, Edward Abadir, Robin E Gasiorowski, et al.
Immunology and Cell Biology|January 22, 2016
A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subsetChristian Bryant, Phillip D Fromm, Fiona Kupresanin, et al.
Science (New York, N.Y.)|August 10, 2019
Black carbon lofts wildfire smoke high into the stratosphere to form a persistent plumePengfei Yu, Owen B Toon, Charles G Bardeen, et al.
Molecular Oncology|July 25, 2019
CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiationEdward Abadir, Robin E Gasiorowski, Kaitao Lai, et al.
Oncoimmunology|April 11, 2018
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remissionJennifer L Hsu, Christian E Bryant, Michael S Papadimitrious, et al.
Science Advances|December 10, 2025
Enhanced radiative cooling by large aerosol particles from wildfire-driven thunderstormsYaowei Li, John A Dykema, David A Peterson, et al.
Haematologica|January 21, 2018
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphomaZiduo Li, Xinsheng Ju, Kenneth Lee, et al.
Pageof 14